ALNY vs BTBDW · P/E 76, rev $1.29B vs P/E 0.3
Alnylam Pharmaceuticals Inc (ALNY) versus BT Brands Inc. Warrant (BTBDW) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
BT Brands Inc. Warrant (BTBDW) is a restaurants company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
BTBDW does not have a complete income-statement cache yet.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BTBDW currently screens at market cap $0 and trailing P/E 0.3.
Not investment advice. Open the ALNY and BTBDW stock pages for the full models.
Not investment advice.